Jean Corsan Foundation

The Jean Corsan Foundation is a family-governed charitable trust driven by a mission to protect public health through advancing medical research into Alzheimer’s disease, dementia, and other neurodegenerative disorders of the brain and nervous system. Rooted in lived experience of dementia, its core values emphasize scientific excellence, researcher career development, practical application of discoveries for prevention, treatment, and cure, and public education to disseminate knowledge. Their grantmaking philosophy prioritizes targeted, selective support for outstanding research projects and early-career talent, believing transformative impact arises from sustaining high-quality neurodegeneration science that accelerates clinical translation and improves outcomes for those affected by brain diseases.

They fund medical research excellence in Alzheimer’s disease, dementia, and neurodegenerative conditions including Parkinson’s and motor neuron disease, supporting early-career researchers such as UK-based PhD and MD/PhD students through prestigious prizes for breakthrough scientific papers in neurodegeneration. Key activities include sponsoring dedicated research posts at leading universities to drive innovative studies on disease mechanisms, biomarkers, and therapeutic interventions, backing strategic initiatives like clinical acceleration programs to expedite promising dementia treatments from lab to patient trials, and promoting public education on brain health, risk factors, and emerging therapies. They prioritize research addressing cognitive decline, neuronal degeneration, neuroinflammation, and synaptic dysfunction in aging populations, fostering clinician-scientist collaborations to bridge basic science and applied neurology, with ultimate impact on prevention strategies, disease-modifying treatments, and care innovations for dementia patients and families.

They exclude non-research activities, project or unrestricted grants to external charities via open calls, and work outside neurodegeneration relevance or scientific quality. Distinctive for family stewardship honoring personal dementia experience, they uniquely champion next-generation neuroscientists tackling Alzheimer’s and related brain disorders, focusing on UK research communities, clinician-researchers, and indirect beneficiaries—elderly individuals, families, and carers facing dementia’s cognitive, behavioral, and neurological challenges—through evidence-based, high-impact science rather than direct services.